Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States

View Resource

Examines access to and availability of molecular tumor boards (MTBs) and comprehensive genomic profiling (CGP) to improve cancer outcomes in rural patients. Examines data from 151 patients from rural North Carolina enrolled in a clinical cancer trial and examines cancer types, actionable biomarkers, and provider feedback on barriers to enrollment in patient trial clinicals in rural areas.

Anivarya Kumar, Jennifer R. Owen, Nicholette T. Sloat, et al.

Current Oncology, 1(11), 7244-7257

11/2024

Document

Access · Cancer · Specialty care · Statistics and data · North Carolina